AlphaCore Capital LLC Acquires New Position in Leidos Holdings, Inc. $LDOS

Leidos reported a quarterly beat on November 4 with EPS of $3.05 versus $2.61 consensus and revenue of $4.47B versus $4.28B, delivering a net margin of 8.11% and ROE of 33.02%. Management set FY2025 EPS guidance of $11.45–11.75 while analysts have raised price targets and ratings (consensus target $199.23, MarketBeat average “Moderate Buy”), and the board increased the quarterly dividend to $0.43 ($1.72 annualized, 0.9% yield). Institutional ownership is high (~76.1%), several funds initiated or boosted positions and an insider sold 12,497 shares (minor dilutive signal), leaving the stock with a market cap of $24.5B and a P/E of 17.87.

Analysis

Market Structure: Leidos (LDOS) benefits directly from sustained U.S. defense and civil IT spending — wins here lift systems integrators (e.g., BAH, SAIC) and hurt smaller niche contractors lacking scale. The EPS beat and FY25 guide (11.45–11.75) imply backlog conversion and pricing stability; with P/E ~17.9 vs. historical 18–22 range, incremental market share gains could be priced in over 6–12 months. High institutional ownership (76%) increases momentum risk on inflows/outflows and makes 10–15% intraday moves more likely around contracts or budget headlines.

Risk Assessment: Tail risks include a major program cancellation/bid protest or a US budget sequestration scenario (10–20% civil cut) that could reduce revenues by several hundred million over 12–24 months; cyber or classified program delays are second-order but can materially compress margins. Immediate risk (days) is IV repricing post-upgrade; short-term (weeks–months) is execution vs. FY25 guide; long-term (quarters) is integration of acquisitions and DoD award concentration (client concentration risk). Monitor backlog disclosure, D/E ~0.94, and quarterly free cash flow within 30–90 days as triggers.

Trade Implications: Construct a core-long: establish a 2–3% portfolio long in LDOS at spots ≤$195 with a 12-month target $235 (Bank of America) and hard stop $170 (10–13% below entry). Pair trade: long LDOS vs short Booz Allen (BAH) 1–1 to capture IT services share gains; target spread capture 10–15% over 6–12 months. Options: buy Jan 2026 LEAP 202.5–205 calls (delta ~0.45–0.55) as directional, or sell 30–45 day calls against a small long base to harvest premium if IV>25%.

Contrarian Angles: Consensus "Moderate Buy" may underweight downside from lumpiness of classified revenue and insider selling (Sept) — insider reduction signals liquidity or rebalancing, not necessarily fundamental weakness. The market may underprice recurring civil-health services expansion; if Leidos sustains margins above 9% net and converts guidance to consensus-beating results, upside to $235 becomes likely within 9–12 months. Conversely, if FY25 quarterly cadence slips, expect a 15–25% downside re-rating given high multiple sensitivity.

Key Decisions for Investors

• Establish a 2–3% portfolio long position in LDOS at or below $195; set a 12‑month target of $235 and a stop-loss at $170 to limit downside to ~10–13%.
• Implement a pair trade: go long LDOS and short Booz Allen (BAH) equal notional (1:1) sized to 1–2% net exposure, target spread profit of 10–15% over 6–12 months as Leidos converts IT/defense backlog.
• Buy Jan 2026 LEAP calls on LDOS (strike ~202.5–205) sized to 0.5–1% portfolio exposure to capture secular upside; alternatively sell 30–45 day calls to collect premium if IV>25% while holding a smaller core long.
• Reduce or avoid exposure to small-cap defense IT contractors lacking classified program access; rotate 3–5% of portfolio into large-cap defense names (LDOS, NOC, RTX) if H1 2025 DoD budget passages look constructive (monitor votes over next 60–120 days).
• Monitor three near‑term catalysts before adding size: monthly backlog/procurement disclosures (next 30 days), FY25 quarterly cadence vs guide (next 90 days), and any >$250M bid protests/award announcements; if two are negative, cut exposure by half.